Praxis Precision medicine

Praxis is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal imbalance. They are applying knowledge of gene mutations that cause neuronal imbalance to develop approaches addressing prevalent psychiatric and neurological conditions as well as rare diseases. They have built a broad portfolio comprising five disclosed programs targeting multiple CNS disorders, including depression, epilepsy, movement disorders, and pain syndromes.